ANUBISMED

Active substance: ALLANTOIN, ALOE VERA LEAF, FRAGRANCE 13576, GLYCERYL MONOSTEARATE, TROLAMINE, BUTYLATED HYDROXYTOLUENE, PROPYLENE GLYCOL, CETYL ALCOHOL, TROPOLONE, TOCOPHEROL, DIMETHICONE, 1,2-HEXANEDIOL, IMIDUREA, CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE, CETEARYL ETHYLHEXANOATE, MEDIUM-CHAIN TRIGLYCERIDES, CAPRYLYL GLYCOL, OCTINOXATE, GLYCERIN, GLYCERYL STEARATE SE, WATER, C12-20 ACID PEG-8 ESTER, OXYBENZONE, DECYL OLEATE

CREAM · ALLANTOIN .05 g/50mL, ALOE VERA LEAF 2.5 g/50mL, FRAGRANCE 13576 .225 g/50mL, GLYCERYL MONOSTEARATE .875 g/50mL, TROLAMINE .3 g/50mL, BUTYLATED HYDROXYTOLUENE .0535 g/50mL, PROPYLENE GLYCOL 1.996 g/50mL, CETYL ALCOHOL .0038 g/50mL, TROPOLONE .004 g/50mL, TOCOPHEROL .0004 g/50mL, DIMETHICONE .25 g/50mL, 1,2-HEXANEDIOL .198 g/50mL, IMIDUREA .15 g/50mL, CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE .25 g/50mL, CETEARYL ETHYLHEXANOATE 1.75 g/50mL, MEDIUM-CHAIN TRIGLYCERIDES 1.5 g/50mL, CAPRYLYL GLYCOL .198 g/50mL, OCTINOXATE 3.4965 g/50mL, GLYCERIN .4975 g/50mL, GLYCERYL STEARATE SE 1.5 g/50mL, WATER 27.4065 mL/50mL, C12-20 ACID PEG-8 ESTER 2.25 g/50mL, OXYBENZONE 2 g/50mL, DECYL OLEATE 1.9996 g/50mL

United StatesActive

Marketing holder: ANUBIS COSMETICS SL

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

ALLANTOIN · .05 g/50mL
ALOE VERA LEAF · 2.5 g/50mL
FRAGRANCE 13576 · .225 g/50mL
GLYCERYL MONOSTEARATE · .875 g/50mL
TROLAMINE · .3 g/50mL
BUTYLATED HYDROXYTOLUENE · .0535 g/50mL
PROPYLENE GLYCOL · 1.996 g/50mL
CETYL ALCOHOL · .0038 g/50mL
TROPOLONE · .004 g/50mL
TOCOPHEROL · .0004 g/50mL
DIMETHICONE · .25 g/50mL
1,2-HEXANEDIOL · .198 g/50mL
IMIDUREA · .15 g/50mL
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE · .25 g/50mL
CETEARYL ETHYLHEXANOATE · 1.75 g/50mL
MEDIUM-CHAIN TRIGLYCERIDES · 1.5 g/50mL
CAPRYLYL GLYCOL · .198 g/50mL
OCTINOXATE · 3.4965 g/50mL
GLYCERIN · .4975 g/50mL
GLYCERYL STEARATE SE · 1.5 g/50mL
WATER · 27.4065 mL/50mL
C12-20 ACID PEG-8 ESTER · 2.25 g/50mL
OXYBENZONE · 2 g/50mL
DECYL OLEATE · 1.9996 g/50mL

Products containing allantoin in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
RU 7	Йокс®-Тева спрей для местного применения, ~, 30 мл (original in Russian, GRLS) ЛП-№(005857)-(РГ-RU) Тева Фармацевтические Предприятия Лтд. Йокс®-Тева спрей для местного применения, ~, 30 мл (original in Russian, GRLS) П N014300/02 Тева Фармацевтические Предприятия Лтд. Гепатромбин крем для наружного применения, (500 МЕ+3 мг+4 мг)г, 40 г (original in Russian, GRLS) П N011078/01 Хемофарм А.Д. Гепатромбин гель для наружного применения, (500 МЕ+2.5 мг+2.5 мг)/г, 40 г (original in Russian, GRLS) П N011078/02 Хемофарм А.Д. Гепатромбин крем для наружного применения, (300 МЕ+3 мг+4 мг)/г, 40 г (original in Russian, GRLS) П N013949/01 Хемофарм А.Д. All products in this country (7)

Country

Products

RU 7

Йокс®-Тева
спрей для местного применения, ~, 30 мл (original in Russian, GRLS)
ЛП-№(005857)-(РГ-RU)
Тева Фармацевтические Предприятия Лтд.
Йокс®-Тева
спрей для местного применения, ~, 30 мл (original in Russian, GRLS)
П N014300/02
Тева Фармацевтические Предприятия Лтд.
Гепатромбин
крем для наружного применения, (500 МЕ+3 мг+4 мг)г, 40 г (original in Russian, GRLS)
П N011078/01
Хемофарм А.Д.
Гепатромбин
гель для наружного применения, (500 МЕ+2.5 мг+2.5 мг)/г, 40 г (original in Russian, GRLS)
П N011078/02
Хемофарм А.Д.
Гепатромбин
крем для наружного применения, (300 МЕ+3 мг+4 мг)/г, 40 г (original in Russian, GRLS)
П N013949/01
Хемофарм А.Д.

All products in this country (7)

Registration

Registration number: 83021-750
Registration status: Active
Dispensing: Over the counter
Route: TOPICAL

Sources

product · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.18 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.19 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.20 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.21 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.22 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source
ingredients.23 · openFDA NDC · 83021-750 · Verified 2026-10-09 · open in source